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Factors AssociatedWithMeasles Transmission
in the United States During the Postelimination Era
Paul A. Gastañaduy, MD, MPH; Sebastian Funk, PhD; Benjamin A. Lopman, PhD; Paul A. Rota, PhD; Manoj Gambhir, PhD;
Bryan Grenfell, DPhil; Prabasaj Paul, PhD
IMPORTANCE Measles cases and outbreaks continue to occur in the United States after the
introduction of measles from endemic settings.
OBJECTIVE To discern the factors associated with measles transmission in the United States
after measles had been eliminated.
DESIGN, SETTING, AND PARTICIPANTS This cross-sectional studywas conducted from January
1, 2001, to December 31, 2017, in the United States among US residents and international
visitors with confirmedmeasles. A maximum likelihood algorithm that uses the observed
dates of rash onset and the known distribution of the serial interval (time between symptom
onset in related consecutive cases) was applied to outbreak notification data to estimate the
effective reproduction number (R), or themean number of new infections generated per
case. Transmissibility was assessed by comparing R based on the characteristics of primary
and secondary cases of measles.
EXPOSURESMeasles virus.
MAIN OUTCOMES ANDMEASURES Effective reproduction number (R), or themean number of
successful transmission events per case of measles (ie, the mean number of persons to whom
each patient with measles spreads measles).
RESULTS A total of 2218 individuals with confirmedmeasles cases (1025 female, 1176male,
and 17 sex not reported; median age, 15 years [range, 0-89 years]) reported from 2001 to
2017 were evaluated. Among patients who received no doses of measles vaccine, Rwas 0.76
(95% CI, 0.71-0.81); among patients who received 1 dose of measles vaccine, Rwas 0.17
(95% CI, 0.11-0.26); among patients who received 2 doses or more of measles vaccine, Rwas
0.27 (95% CI, 0.17-0.39); and among patients with unknown vaccination status, Rwas 0.52
(95% CI, 0.44-0.60). Among patients born before 1957, Rwas 0.35 (95% CI, 0.20-0.58), and
among those born on or after 1957, Rwas 0.64 (95% CI, 0.61-0.68). Rwas higher when
primary and secondary cases of measles were patients aged 5 to 17 years (0.36 [95% CI,
0.31-0.42]) compared with assortative transmission in other age groups (<1 year, 0.14
[95% CI, 0.10-0.20]; 1-4 years, 0.25 [95% CI, 0.20-0.30]; 18-29 years, 0.19 [95% CI,
0.15-0.24]; 30-49 years, 0.15 [95% CI, 0.11-0.20];50 years, 0.04 [95% CI, 0.01-0.10]).
CONCLUSIONSANDRELEVANCE The findings of this study support having high targets for
2-dosemeasles vaccine coverage, particularly among school-aged children in theUnited States.
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G lobal coverage with the first dose of a measles vac-cine has plateaued at approximately 85% since 2010,increases in measles incidence have been noted in 5
of the 6WorldHealthOrganizationRegions since 2016, and at
least 1 country in the Americas, Venezuela, has reestablished
endemicmeasles virus transmission.1 The decelerating prog-
ress in global elimination efforts implies thatmeasles will re-
main endemic in many parts of the world and that the virus
will continue to test immunity levels in elimination settings
for the foreseeable future. Sizeable outbreaks have recently
occurred in several US states (eg, NewYork,Washington, and
NewJersey)2 and inother countries (eg, Canada,Vietnam, and
the Philippines), pointing to heterogeneity in vaccination
coverage.
Factors other than lack of vaccinationmight contribute to
measlesvirus transmission insettingswithmaturecontrolpro-
grams.First, aswithother respiratory illnesses,measles trans-
mission is affected by contact patterns, particularly mixing
within andbetween age groups.3 Second, intense contact and
highpopulationdensity (eg, in schoolsandmetropolitanareas)
have been associated with an increased risk for measles
outbreaks.4,5 Third, studies have shown reduced antibody
responses6 and a higher risk for measles7 when the first dose
of the measles vaccine is administered at 12 to 14 months of
age comparedwithwhen the vaccine is given at 15months of
age or older. Fourth, in the absence of boosting from wild-
typedisease, vaccine-inducedantibody titers areknowntode-
cline over time,8 and vaccinated persons are potentially sus-
ceptible to infection and disease as a result of waning
immunity.9 The ability of vaccine nonresponders and of indi-
viduals with waning immunity to transmit measles is poorly
understood.
Abetter understandingof the factors affectingmeasles vi-
rus transmission could help improve the allocation of public
health resources formeasles prevention and control in elimi-
nationandnear-elimination settings.Weaimed todiscern fac-
tors associatedwithmeasles virus transmission in theUnited
States after elimination.
Methods
Measles is nationally notifiable in the United States.10,11
Cases are reported by health care professionals and clinical
laboratories, investigated by local and state health depart-
ments, classified according to standard case definitions,
linked into clusters epidemiologically, and reported to the
Centers for Disease Control and Prevention.10,11 We analyzed
available information on all confirmed cases of measles in
the United States from January 1, 2001, to December 31,
2017. Data were collected as part of standardized public
health surveillance and determined by the Centers for Dis-
ease Control and Prevention not to be research involving
human participants.
In this cross-sectional study, we measured the transmis-
sibility of measles by estimation of the effective reproduc-
tionnumber (R),ormeannumberofsecondarycasesofmeasles
generatedper single infectious individual in apopulationwith
some level of immunity (the basic reproduction number, R0,
describes transmissibility in a fully susceptible population).
Sustainingmeasles elimination requiresmaintenanceofRbe-
low the threshold value of 1. IfR is greater than 1, on average,
each person spreads measles to more than 1 other person,
and a self-sustaining outbreak can occur; by contrast, if R is
less than 1, on average, each person spreads measles to less
than 1 other person, and transmission cannot be sustained.
Building on previous analyses,12,13 we adapted an existing
algorithm14,15 thatusesamaximumlikelihoodprocedure to in-
fer R for each case, or cohort of cases, given the time in days
betweencases inanoutbreakand theprobabilitydensity func-
tion of the serial interval (time between the onset of symp-
toms inprimarycasesofmeasles and the secondary cases they
generate).14,15Weusedaserial interval formeaslesderivedfrom
household transmission studieswith a γ probability distribu-
tion and amean (SD) of 11.1 (2.5) days.16 In brief, in any given
measles case series, the weight that patient i infected patient
j,Wij, is the serial interval distribution applied to the number
ofdaysbetweentherashonsetsofpatients iand j, andtheprob-
ability that patient j was infected by patient i, Pij, is given by
Pij = Wij/(kWkj),where the sum in thedenominator is over all
potential infectors k of patient j. The estimate of the R for
patient i is Ri = jPij (eMethods in the Supplement).
We applied the method to measles surveillance data by
performing the procedure for all cases of measles after the
index case (first identified case in a transmission chain) in
each reported cluster of cases (2-case chains and outbreaks
of ≥3 cases). The algorithm assigns singleton cases (single
cases with no other cases epidemiologically linked to them)
an R of 0.
Chains of transmission in which 2 consecutive cases of
measles are too close or too far away in time based on the dis-
tributionof theserial intervalandthatareunexplainedbyother
cases in the outbreak are likely to be an artifact of surveil-
lance (eg, an unidentified common source or a missing case
in a chain) and may erroneously be considered a transmis-
sion pair by themodel. To account for this possibility, if a sec-
ondary case could not be ascribed to a case of measles
presenting 6 through 18 days prior (ie, the observed range of
Key Points
Question What are the factors causing the transmission of
measles in long-standingmeasles control programs?
Findings This cross-sectional study found that lack of vaccination
and birth on or after 1957, as well assortative transmission by age
(particularly among school-aged children), are the primary factors
associated with measles transmission in the United States.
Although current measles vaccines are known to be highly
effective in decreasing susceptibility to measles, these analyses
shed light on the degree by which vaccination also limits measles
transmission.
Meaning The findings underscore the importance of maintaining
homogenous, high, 2-dosemeasles vaccine coverage, especially
among school-aged children, to sustain elimination of measles in
the United States.
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serial intervalvalues17 andequivalent to thecentral95%CIpro-
file of the serial interval),16 the supposed connection was ex-
cludedand the secondarycasewas reassignedasan indexcase
and the procedure continued. Thismethod allowed for inclu-
sion in the analyses of all transmissions before and after the
supposed transmission between consecutive cases.
When there is more than 1 measles case in any particular
day of an outbreak, the method averages the number of for-
wardtransmissionsoriginating fromthecohortofpatientswith
measles presenting that day,14 thereby increasing or decreas-
ing the estimated contribution of any given case to transmis-
sion. However, the resolution of cases driving the transmis-
sion in each cohort can be improved by weighting the
transmissibility of each case in a given day by characteristics
associated tomeasles transmissibility.Weweighted the trans-
missibility of each case in a given day by the number of doses
of a measles-containing vaccine received (0, 1, ≥2, or un-
known) and whether the patient was born before 1957 or on
or after 1957.Weadjusted transmissibility specificallyby these
2 factors because receipt of measles vaccine and birth in the
prevaccineera (ie,before1957)areconsideredpresumptiveevi-
dence of measles immunity,11 and levels of immunity are
thought to be linked to the capacity to transmit the virus
(eMethods and eTable 1 in the Supplement).9,18,19
We assessed R based on the following characteristics of
patients with measles: vaccination status (0, 1, or ≥2 doses or
unknown),birthprior to 1957 (presumed immune fromnatural
exposure), sex, importation status (imported or US-acquired),
residencystatus (USresidentor foreignvisitor), age (inmonths)
at firstdose, time(years)sincevaccination,hospitalization,pres-
ence of complications, reporting US state, and genotype. We
dichotomized age at first dose (<15 or ≥15months), as previous
studies indicate reducedantibodyresponsesand increasedsus-
ceptibility to measles when the first dose is given before 15
monthsofage.6,7Toevaluate forchanges in transmissibilitydue
towaning immunity, we dichotomized time since vaccination
(<12or≥12years),with12yearsbeingthemediannumberofyears
since vaccination for available data. In addition, we evaluated
Rbasedonthevaccinationstatus (0doses,≥1dose,orunknown)
andagegroup (<1, 1-4, 5-17, 18-29,30-49,and≥50years)ofboth
primarycasesofmeaslesandthesecondarycasesofmeaslesthat
they generated.
Wedescribe thedemographicandepidemiologiccharacter-
isticsofpotential superspreadingevents,definedasacasewith
anestimatedRgreater thanorequal to5 (≥99thpercentileof all
estimates in thisdata set). Sensitivity analyseswereperformed
to examine the choice of themeasles serial interval, thewidth
of the time window for allowable connections to be made be-
tweenconsecutivecases,andthecharacteristics included inthe
weighting procedure to determine the factors associated with
transmission (eResults in the Supplement).
Results
From 2001 to 2017, a total of 2218 confirmed measles cases
were reported in the United States. Of these, 490 were single
cases, 90 were 2 case-chains, and 116 were outbreaks of 3
or more cases. The median size of outbreaks was 5 cases
(range, 3-383 cases) and median duration of outbreaks
was 22 days (range, 3-121 days). Among the 2218 measles
cases, 573 (25.8%) were internationally imported and 1645
(74.2%) were acquired in the United States. Most patients
with measles were unvaccinated (1508 [68.0%]) or had an
unknown vaccination status (435 [19.6%]). The date of vac-
cine receipt was poorly populated in our data set (available
for 100 of 275 vaccinated individuals [36.4%]). Additional
key characteristics of measles cases are shown in eTable 2 in
the Supplement. A graphical representation of the transmis-
sion matrix for one outbreak is shown in the eFigure in the
Supplement.
Estimates of R for measles in the United States were 0.76
(95%CI,0.71-0.81) amongpatientswhohad receivednodoses
ofameasles-containingvaccine,0.17 (95%CI,0.11-0.26)among
patients who had received 1 dose, 0.27 (95% CI, 0.17-0.39)
among patients who had received 2 or more doses, and 0.52
(95% CI, 0.44-0.60) among those who had an unknown vac-
cination status. Among patients born before 1957, Rwas 0.35
(95% CI, 0.20-0.58), and among those born on or after 1957,
Rwas 0.64 (95% CI, 0.61-0.68) (Figure 1).
Among unvaccinated primary cases ofmeasles in patients
who infected unvaccinated and vaccinated (≥1 doses) second-
ary casesofmeasles,Restimateswere0.61 (95%CI,0.57-0.65)
amongunvaccinated individuals and0.06 (95%CI,0.05-0.08)
amongvaccinatedindividuals.Amongvaccinatedprimarycases
ofmeasles inpatientswhoinfectedunvaccinatedandvaccinated
secondarycasesofmeasles,Restimateswere0.10(95%CI,0.06-
0.15) amongunvaccinated individuals and0.07 (95%CI,0.04-
0.11) among vaccinated individuals (Table 1).
Transmission was generally assortative by age groups
(ie, transmission tended to be higher between individuals of
a similar age group). R estimates were higher when primary
andsecondarycasesofmeasleswerepatientsaged5 to 17years
(0.36 [95% CI, 0.31-0.42]) compared with assortative trans-
mission in other age groups (<1 year, 0.14 [95% CI, 0.10-
0.20]; 1-4 years, 0.25 [95% CI, 0.20-0.30]; 18-29 years, 0.19
Figure 1. Estimates of theMeasles Case Reproduction Number, R,
by Vaccination Status and Birth Before 1957
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The bars represent the 95% CIs, and the horizontal dashed line indicates the
threshold value of R = 1. Results are self-consistently adjusted by the number
of doses of a measles-containing vaccine received and birth before 1957.
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[95% CI, 0.15-0.24]; 30-49 years, 0.15 [95% CI, 0.11-0.20];
≥50 years, 0.04 [95% CI, 0.01-0.10]) (Table 2).
Estimates of R were not substantially different based on
sex, residence status, hospitalization, age at first dose, or
time since vaccination (Figure 2). Estimates of R among
patients who acquired measles abroad was estimated to be
0.56 (95% CI, 0.50-0.62) and among patients who acquired
measles in the United States to be 0.67 (95% CI, 0.63-0.71).
Estimates of R among patients reporting complications was
0.76 (95% CI, 0.66-0.88) and among those not reporting
complications was 0.62 (95% CI, 0.59-0.66). Some differ-
ences in R estimates were seen based on the genotype and
reporting state (Figure 3); some of these estimates were
based on few cases, and most 95% CIs overlapped.
We identified 23 possible superspreading events during
the study period (median R = 6.1 [range, 5.0-18.1]) (eTable 3
in the Supplement). The median age of superspreaders was
17 years (range, 9 months-63 years). Nineteen of the 23 indi-
viduals (82.6%) were unvaccinated (the remaining 4 had an
unknown vaccination status), and 22 (95.7%) were born on
or after 1957. Superspreading events occurred during 16 out-
breaks (typically early in the outbreak), which had a median
size of 21 cases (range, 6-383 cases) and median duration of
44 days (range, 18-121 days). Superspreading events occurred
mostly in close-contact settings (eg, hospitals, households,
and schools), and most individuals with measles reported in
these outbreaks were unvaccinated.
Sensitivity analyses showed that varying several of the
assumptions in this evaluation resulted in only small
changes in general patterns of transmission (eTables 4-12 in
the Supplement).
Discussion
By pooling means of R based on various case characteristics,
we were able to discern the factors associated with measles
transmission in this postelimination setting. Principally, we
found a gradient of transmission in which unvaccinated pa-
tients with measles are approximately 3 to 4 times more in-
fectious comparedwithpatientswithmeasleswhohavebeen
vaccinated once or twice, and that transmission is concen-
trated among unvaccinated primary and secondary cases of
measles. Furthermore, our description of superspreading
eventshighlight lackofvaccinationas the initial spark for large
outbreaks ofmeasles. Although themeasles vaccine is known
to be highly effective in decreasing measles susceptibility—1
dose is 93% effective againstmeasles and 2 doses are 97% ef-
fective—our findings also suggest an association of vaccina-
tion with limiting measles communicability and underscore
the fact thatmeasles transmission in theUnitedStates isdriven
by failure to vaccinate rather than a failure of vaccine perfor-
mance. In addition, the low transmissibility observed from
adults born when measles was still endemic (assumed to be
naturally infected) supports theuseof birthbefore vaccine in-
troductionas acceptablepresumptiveevidenceofmeasles im-
munity in elimination settings.11
Measles transmissionwasassortativewithage (amongper-
sons aged <50 years, approximately 30%-50% of transmis-
sion events occurred within the same age group), consistent
with age-specificmixing reported in studies that quantify so-
cial encounters that are potentially infectious.3 A key feature
associatedwith thepreferential interactionwithin age groups
is the finding of more pronounced contacts among school-
aged children (relative to contacts between adults).3 Our
evaluation similarly shows school-aged children as a primary
conduit ofmeasles transmission in theUnited States and em-
phasizes the importance of policies aimed at ensuring high
2-dosevaccine coverageof these children (eg, school entry im-
munization requirements)orpresumptivecommunication (in-
forming parents that vaccines are scheduled during the visit)
insteadofparticipatory communication (askingparents if they
would like their children to be vaccinated) during parent-
clinician encounters.20Age-specificR estimates derived from
Table 2. Estimates of theMeasles Reproduction Number, R, Among Primary and Secondary Cases ofMeasles, by Age Groupa
Age Group of Primary Cases
Age Group of Secondary Cases, R (95% CI)
<1 y 1-4 y 5-17 y 18-29 y 30-49 y ≥50 y
<1 y 0.14 (0.10-0.20) 0.12 (0.08-0.19) 0.09 (0.05-0.15) 0.07 (0.04-0.12) 0.05 (0.03-0.10) 0.009 (0.002-0.03)
1-4 y 0.08 (0.05-0.12) 0.25 (0.20-0.30) 0.14 (0.11-0.19) 0.09 (0.06-0.12) 0.10 (0.07-0.14) 0.02 (0.008-0.04)
5-17 y 0.04 (0.03-0.07) 0.10 (0.08-0.14) 0.36 (0.31-0.42) 0.12 (0.09-0.16) 0.11 (0.08-0.14) 0.01 (0.005-0.03)
18-29 y 0.06 (0.04-0.09) 0.10 (0.07-0.13) 0.19 (0.15-0.25) 0.19 (0.15-0.24) 0.13 (0.09-0.17) 0.02 (0.01-0.05)
30-49 y 0.05 (0.03-0.08) 0.07 (0.04-0.10) 0.11 (0.08-0.16) 0.11 (0.08-0.16) 0.15 (0.11-0.20) 0.02 (0.01-0.04)
≥50 y 0.07 (0.03-0.15) 0.07 (0.03-0.16) 0.12 (0.06-0.24) 0.13 (0.06-0.25) 0.14 (0.07-0.25) 0.04 (0.01-0.10)
a Results are self-consistently adjusted by the number of doses of a measles-containing vaccine received and birth before 1957.
Table 1. Estimates of theMeasles Reproduction Number, R,
Among Primary and Secondary Cases ofMeasles, by Vaccination Statusa
Vaccination Status of Primary Cases
Vaccination Status of Secondary Cases, R (95% CI)
Unknown Dose(s)b 0 Dosesb ≥1 Dose(s)b
Unknown dose(s)b 0.16 (0.12-0.20) 0.27 (0.22-0.34) 0.09 (0.06-0.12)
0 Dosesb 0.09 (0.08-0.11) 0.61 (0.57-0.65) 0.06 (0.05-0.08)
≥1 Dose(s)b 0.05 (0.03-0.09) 0.10 (0.06-0.15) 0.07 (0.04-0.11)
a Results are self-consistently
adjusted by the number of doses of
a measles-containing vaccine
received and birth before 1957.
bDoses of a measles-containing
vaccine; doses were counted if
given at least 1 maximum incubation
period (21 days) prior to the onset
of rash.
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the probabilistic model14,15 could help clarify the extent by
which social contact patterns explain disease transmission.21
Restimates amongvaccinatedpatientswithmeasleswere
generally very low, including toward unvaccinated cases
(R = 0.10).Theseestimatesmightbebiasedbecausewedidnot
differentiate betweenprimary vaccine failure (failure to sero-
convert after vaccination) andsecondaryvaccine failure (wan-
ing of immunity after seroconversion), and cases of measles
Figure 2. Estimates of theMeasles Case Reproduction Number, R, by Various Case Characteristics
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The bars represent the 95% CIs, and the horizontal dashed line indicates the threshold value of R = 1. Results are self-consistently adjusted by the number of doses
of a measles-containing vaccine received and birth before 1957.
Figure 3. Estimates of theMeasles Case Reproduction Number, R, by Reporting State and Genotype
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A, R estimates for selected states. Forty-seven US states, Washington, DC, and
New York City reportedmeasles cases during the study period. New York City
Department of Health andMental Hygiene and New York State Department of
Health report separately. State data shown are for localities reporting 20 or
more cases of measles, ordered by R point estimates: Utah (UT), 22; Michigan
(MI), 28; Oregon (OR), 28; Kansas (KS), 29; North Carolina (NC), 32; New York
(NY), 41; New Jersey (NJ), 42; Florida (FL), 48; Missouri (MO), 48; Hawaii (HI),
58; Texas (TX), 59; Pennsylvania (PA), 63; Arizona (AZ), 64; Massachusetts
(MA), 68; Illinois (IL), 70; Indiana (IN), 73; Washington (WA), 105; Minnesota
(MN), 121; New York City (NYC), 213; Ohio (OH), 397; and California (CA), 419.
Measles cases are reported by state of residence, whichmay not necessarily be
where the infection was acquired. B, R estimates for selected genotypes.
Genotype data shown are for 8 genotypes identified in 15 or more cases,
ordered by R point estimates: D9, 439; D5, 68; B3, 530; D3, 19; D8, 339; D4,
264; H1, 86; and D7, 15. The bars represent the 95% CIs, and the horizontal
dashed line indicates the threshold value of R = 1. Results are self-consistently
adjusted by the number of doses of a measles-containing vaccine received and
birth before 1957.
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owing to primary vaccine failuremight be as transmissible as
casesofmeasles inunvaccinated individuals. Individualswith
secondary vaccine failure have a vigorous amnestic response
to measles and thus might have milder symptoms and shed
lessvirus.9,18,22Thepresenceof complications (amarkerofdis-
ease severity)was independentlyassociatedwithmeasles con-
tagiousness. The largely restricted transmission of measles
fromvaccinatedpersons is in agreementwithprevious obser-
vations of no transmission from twice-vaccinated individu-
alswithmeasleswhodevelop robust antibody responses (de-
spite exposing numerous persons).9,18,19 Because almost all
persons who do not respond to the first dose of measles vac-
cineareexpected todevelopprotective immunityafter thesec-
ond dose, our study provides further evidence for use of a
2-dose schedule in elimination efforts. Because measles an-
tibody titers are known to decline slowly after measles
vaccination,8 continuedmonitoring ofmeasles among vacci-
nated persons is warranted in low-incidence settings.
Therewere subtle differences in transmissibility basedon
other factors. Comparedwithmeasles among foreign visitors
and imported cases of measles, R values for cases of measles
amongUS residents andUS-acquired cases ofmeasles tended
to be higher. This finding might reflect the transitory nature
of stays by foreign visitors and that they are less likely to con-
tact local at-riskcommunities.Althoughsomedifferenceswere
alsonoted inRpoint estimates basedongenotype and report-
ing state, 95%CIsoverlapped formanyof theseestimates. The
results presented here do not indicate that genotype B3 has
increased transmissibility comparedwith other genotypes.23
Because the chance ofmeasles spreading is dependent on the
setting in whichmeasles is introduced, differences in the ob-
served transmissibility of a given genotype should be inter-
preted cautiously. For example, the higher R for Ohio and D9
is associated with an outbreak in an Amish community in
2014,24 likely owing to this communitybeinghighlyunderim-
munized rather than to any characteristic of thevirus (exclud-
ing this outbreak, theR estimates forOhiowas0.16 and forD9
was 0.71). Other genotypes have been associated with large
outbreaks in other settings (eg, H1 in Mongolia25 and D4 in
France),26 and importationsof thesegenotypesmighthave led
to a similar outbreak in other underimmunized populations
and would not have changed public health response efforts.
Estimation of R associated with specific outbreaks can none-
theless serve as a marker of the extent of a particular immu-
nity gap,27 and careful characterization of these susceptible
communities can help pinpoint areas in which preventive in-
terventions might be needed.28
Limitations
Our study has some limitations. The algorithm14,15 does not
conclusively establish who infected whom and cannot re-
place careful epidemiologic investigation, but it is useful in
identifying the overall direction of transmission. Because the
likelihoodof transmissiondependson several factors, includ-
ing the status (eg, vaccination) of both the infector and in-
fectee, the setting in which the exposure occurred, and out-
break containment interventions, it is challenging to account
for the effect of each potential confounder. For example, we
did not directly evaluate the association of population den-
sitywith transmissionofmeasles, althoughour analysis of su-
perspreading events indicates that close-contact settings
provideopportunities for rapiddisseminationofmeasles.Simi-
larly, we did not evaluate the association of clustering with
transmission ofmeasles, and geographic clustering of unvac-
cinated persons has been linked tomeasles outbreaks.24,29,30
Unvaccinatedprimary casesofmeaslesweremore likely to in-
fectunvaccinated rather thanvaccinated individuals,whereas
vaccinated primary cases of measles infected a similar num-
ber of unvaccinated and vaccinated individuals. Further-
more, the rangeofRvaluesduring superspreading eventswas
similar to the commonly cited range of values for R0.27 Both
observations imply that there are pockets of underimmuni-
zation in the United States. The date of vaccine receipt was
poorly populated in our data set (available for approximately
36% of vaccinated cases), and our results of no difference in
transmissibility by age at first dose and time since vaccina-
tion were based on few cases. These findings were also con-
founded by lack of differentiation between primary and sec-
ondary vaccine failure, which requires specialized testing
(avidity andneutralizing antibody titers).However, our analy-
ses suggest that vaccinated persons are inefficient transmit-
ters ofmeasles, andwe foundnonotable differences in trans-
missibility between vaccinated individuals with measles
with andwithout reported vaccination dates (eTable 13 in the
Supplement). The outbreaks we evaluated occurred in di-
versepopulationsandwereaffectedbyseveral individual- and
context-specific factors; thus, the relative importance of the
different factorsassociatedwithtransmissionmightnotbegen-
eralizable. Finally, our comparisons of R values were qualita-
tive andnot statistical, althoughclear differences in transmis-
sibility were noted and explained by underlying covariates.
Conclusions
The method14,15 we used allowed us to identify leading fac-
tors associated with the spread of measles in an elimination
setting fromhigh-quality surveillancedata.Our findings show
predominantly subcritical (R< 1) transmissionofmeasles and
maintenance of elimination in the United States for the past
17 years,12 establish thepublichealthvalueof themeasles vac-
cine in limitingmeasles infectiousness, andunderscore the im-
portanceofhavinghigh targets for2-dosemeaslesvaccinecov-
erage, especially among school-aged children.
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